Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil

doi:10.5409/wjcp.v11.i4.341

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4551)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

223

WORD

HTML

1983

Figures (1-3)

215

Tables (1-3)

243

Sum=2744

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

455

Download

1352

Sum=1807

Jul 9, 2022 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Pediatr. Jul 9, 2022; 11(4): 341-350
Published online Jul 9, 2022. doi: 10.5409/wjcp.v11.i4.341

Full Size Figure Download Figure

Figure 3 Distribution of medicines for pediatric age inflammatory bowel disease patients in the state of Espírito Santo, from August 2012 to July 2014. SSZ: Sulfasalazine; ASA: Mesalazine; AZA: Azathioprine; MTX: Methotrexate; BIOLOGICAL: Infliximab or adalimumab; UC: Ulcerative colitis; CD: Crohn's disease.

Citation: Martins AL, Fróes RSB, Zago-Gomes MP. Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil. World J Clin Pediatr 2022; 11(4): 341-350
URL: https://www.wjgnet.com/2219-2808/full/v11/i4/341.htm
DOI: https://dx.doi.org/10.5409/wjcp.v11.i4.341